先天性甲状腺功能减退症永久性与暂时性的预测变量评估
该回顾性研究纳入142例2000至2012年诊断的足月先天性甲状腺功能减退症(CH)婴儿,评估早期甲状腺闪烁扫描及临床变量对永久性与暂时性CH的预测价值。结果显示,甲状腺扫描无腺体/异位可预测永久性CH,但原位腺体者无法区分永久与暂时;初始TSH>63.5 mU/L及>6月龄时左甲状腺素剂量>4.6 μg/kg/d预测无腺体/异位,原位腺体者>6月龄时剂量>2.2 μg/kg/d预测永久性CH。
要点
- 早期甲状腺闪烁扫描发现无腺体或异位腺体可预测永久性CH。
- 原位甲状腺者影像学无法区分永久性与暂时性CH。
- 初始TSH>63.5 mU/L预测无腺体/异位腺体。
核心结论
- 早期甲状腺闪烁扫描检测到无腺体或异位腺体时可靠预测永久性CH,但原位甲状腺者无法区分永久与暂时性CH。
- 诊断时确认性TSH及治疗中左甲状腺素剂量可能更好区分永久性与暂时性CH。
研究设计与样本
- 回顾性研究,纳入2000至2012年诊断的142例足月CH婴儿。
- 分为三组:无腺体/异位腺体永久性CH、原位腺体永久性CH、原位腺体暂时性CH。
- 所有患儿均接受早期甲状腺闪烁扫描并定期随访。
主要发现
- 甲状腺扫描显示无腺体/异位腺体58例(41%),原位腺体84例(59%)。
- 原位腺体永久性与暂时性组的影像学表现相似。
- 初始评估时无腺体/异位组TSH高于原位腺体永久组和暂时组(71.5 ± 11.2 mIU/L vs 49.1 ± 27.9 mIU/L和42.5 ± 29.1 mIU/L,P < 0.001)。
- 自第3个月起无腺体/异位组所需左甲状腺素剂量高于原位腺体永久组(P < 0.001),自第6个月起原位腺体永久组高于暂时组(P < 0.01)。
- ROC分析显示初始TSH >63.5 mU/L(P < 0.001)和>6月龄时左甲状腺素剂量>4.6 μg/kg/d(P < 0.001)预测无腺体/异位腺体;原位腺体者>6月龄时剂量>2.2 μg/kg/d(P < 0.01)预测永久性CH。
关键数值与推荐
- 初始TSH >63.5 mU/L预测无腺体/异位腺体(P < 0.001)。
- >6月龄时左甲状腺素剂量>4.6 μg/kg/d预测无腺体/异位腺体(P < 0.001)。
- 原位腺体者>6月龄时左甲状腺素剂量>2.2 μg/kg/d预测永久性CH(P < 0.01)。
临床怎么用
- 早期甲状腺闪烁扫描发现无腺体或异位腺体时,可预计永久性CH并需终身治疗。
- 原位甲状腺者需结合诊断时TSH及治疗中左甲状腺素剂量动态评估永久性与暂时性。
- 治疗中左甲状腺素剂量需求变化可作为区分永久性与暂时性CH的参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess clinical variables, including early thyroid scintigraphy, in predicting the outcome (permanent vs transient) in term infants with congenital hypothyroidism (CH). METHODS: In a retrospective study, 142 full-term infants with CH diagnosed between 2000 and 2012 were categorized into three groups: agenesis/ectopic thyroid and permanent CH; eutopic thyroid and permanent CH; and eutopic thyroid and transient CH. All underwent early thyroid scintigraphy and were under regular follow-up in our tertiary Pediatric Endocrine Institute. RESULTS: Thyroid scan showed agenesis/ectopic thyroid in 58 (41%) and eutopic thyroid in 84 (59%) infants. Imaging findings were similar in eutopic-permanent and eutopic-transient groups. At initial evaluation, TSH levels were higher in the agenesis/ectopic group than in the eutopic-permanent and eutopic-transient groups (71.5 ± 11.2 mIU/L vs 49.1 ± 27.9 mIU/L and 42.5 ± 29.1 mIU/L, respectively; P < 0.001). Higher l-T4 doses were required from the third month in the agenesis/ectopic than in the eutopic-permanent group (P < 0.001) and from the sixth month in the eutopic-permanent than in the eutopic-transient group (P < 0.01). Initial TSH >63.5 mU/L (P < 0.001) and l-T4 dose >4.6 μg/kg/d at age >6 months (P < 0.001) were found to be predictors for an agenesis/ectopic gland using receiver operating characteristic analysis, as was an l-T4 dose >2.2 μg/kg/d at age >6 months (P < 0.01) for permanent CH in patients with a eutopic gland. CONCLUSIONS: Although early thyroid scintigraphy is reliable in predicting permanent CH when detecting agenesis or ectopic gland, it cannot differentiate between permanent and transient CH in cases with a eutopic thyroid. Confirmatory TSH at diagnosis and the l-T4 dose through treatment may better distinguish between permanent and transient CH.
引用
- Oron T, Lazar L, Ben-Yishai S, et al. Permanent vs Transient Congenital Hypothyroidism: Assessment of Predictive Variables. J Clin Endocrinol Metab. 2018. PMID: 30272179. doi:10.1210/jc.2018-00362
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。